For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.
EU rejection based on risk of serious brain swelling Lilly seeks re-examination of EU decision on Kisunla CHMP previously rejected Leqembi before recommending approval March 28 (Reuters) - The EU ...
Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” investor letter for the second quarter of 2025. A copy of the letter can be downloaded here ...
Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
1don MSN
Mikaela Shiffrin works with Lilly to help families of Alzheimer's patients. Families like hers.
She might not have been able to do that for her grandmother. But she can for other families. In honor of her grandmother, ...
Eli Lilly and Company LLY has gained tremendous market value in the past 2-3 years due to the success of its popular GLP-1 drugs, Mounjaro for type II diabetes and Zepbound for obesity. However, Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback